- Filed
- Nov 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 31, 2025 | 55.4M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 55.56M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 54.86M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 62.59M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 53.66M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $36.78M |
| Capex | Q3 2025 · Sep 30, 2024 | $23.65M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $97.14M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $90.68M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $663.44M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $625.43M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $10K |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $29K |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $261.78M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $183.94M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $193.88M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$256.59M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$263.81M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$253.11M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$226.88M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$255.49M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$225.06M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $438.61M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $392.45M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $1.11B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.02B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $363.79M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $278.43M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $976.53M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $876.91M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.00 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.18 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $0.36 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.18 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.00 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.18 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $0.39 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.18 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $34.81M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $98.61M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $29M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $86.07M |
| Net Income | Q3 2025 · Sep 30, 2025 | $1.19M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$6.17M |
| Net Income | Q3 2025 · Sep 30, 2024 | $22.52M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$6.13M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $35.97M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $50.99M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $29.48M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $29.12M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $124.37M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $308.61M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $109.79M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $277.19M |